British Journal of Cancer

Papers
(The H4-Index of British Journal of Cancer is 54. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Correction To: Serplulimab, a novel anti-PD-1 antibody, in patients with microsatellite instability-high solid tumours: an open-label, single-arm, multicentre, phase II trial181
Advancing radiomics from contrast-enhanced mammography in breast cancer165
Correction: Phase 1A/1B dose-escalation and -expansion study to evaluate the safety, pharmacokinetics, food effects and antitumor activity of pamiparib in advanced solid tumours144
Investigation of the gut microbiome, bile acid composition and host immunoinflammatory response in a model of azoxymethane-induced colon cancer at discrete timepoints141
Surveillance after childhood cancer: are survivors with an increased risk for cardiomyopathy regularly followed-up?135
Efficacy of CDK4/6 inhibitors in preclinical models of malignant pleural mesothelioma108
Correction to: Nationwide randomised trial evaluating elective neck dissection for early stage oral cancer (SEND study) with meta-analysis and concurrent real-world cohort106
Randomised, Phase II study of selumetinib, an oral inhibitor of MEK, in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer105
Correction to: EGFR/Ras-induced CCL20 production modulates the tumour microenvironment105
Proactive breast cancer risk assessment in primary care: a review based on the principles of screening102
Years of life lost due to cancer in the United Kingdom from 1988 to 201798
Mutational spectrum of TP53 gene correlates with nivolumab treatment efficacy in advanced gastric cancer (TP53MUT study)95
The EXO1/Polη/Polι axis as a promising target for miR-3163-mediated attenuation of cancer stem-like cells in non-small cell lung carcinoma93
Integrated genomic and transcriptomic analysis reveals the activation of PI3K signaling pathway in HPV-independent cervical cancers93
Combined PARP and HSP90 inhibition: preclinical and Phase 1 evaluation in patients with advanced solid tumours92
Normal weight obesity, circulating biomarkers and risk of breast cancer: a prospective cohort study and meta-analysis91
Cancer therapy with decreased SARS-CoV-2 infection rates in cancer patients90
Hit it hard: qualitative patient perspectives on the optimisation of immune checkpoint inhibition89
Fibroblast growth factor signalling influences homologous recombination-mediated DNA damage repair to promote drug resistance in ovarian cancer86
Hepatitis B virus X protein promotes MAN1B1 expression by enhancing stability of GRP78 via TRIM25 to facilitate hepatocarcinogenesis86
Metastasis-associated fibroblasts in peritoneal surface malignancies85
CD20 expression, TrkB activation and functional activity of diffuse large B cell lymphoma-derived small extracellular vesicles85
Fibroblast activation protein-targeted near-infrared photoimmunotherapy depletes immunosuppressive cancer-associated fibroblasts and remodels local tumor immunity84
Clinicopathological and molecular characteristics of RSPO fusion-positive colorectal cancer82
PANTHER: AZD8931, inhibitor of EGFR, ERBB2 and ERBB3 signalling, combined with FOLFIRI: a Phase I/II study to determine the importance of schedule and activity in colorectal cancer80
Assessments of social vulnerability on laryngeal cancer treatment & prognosis in the US77
Genomic ALK alterations in primary and relapsed neuroblastoma75
Impact of clonal TP53 mutations with loss of heterozygosity on adjuvant chemotherapy and immunotherapy in gastric cancer75
Comprehensive assessment of actionable genomic alterations in primary colorectal carcinoma using targeted next-generation sequencing74
VinCaP: a phase II trial of vinflunine in locally advanced and metastatic squamous carcinoma of the penis71
Correction: YY1 targets tubulin polymerisation-promoting protein to inhibit migration, invasion and angiogenesis in pancreatic cancer via p38/MAPK and PI3K/AKT pathways70
A very-hot food and beverage thermal exposure index and esophageal cancer risk in Malawi and Tanzania: findings from the ESCCAPE case–control studies70
Modulation of autophagy: a Phase II study of vorinostat plus hydroxychloroquine versus regorafenib in chemotherapy-refractory metastatic colorectal cancer (mCRC)68
Detection of recurrences using serum miR-371a-3p during active surveillance in men with stage I testicular germ cell tumours67
Primary tumor sidedness and negative hyperselection to modulate anti-EGFR-based maintenance strategies in patients with RAS wild-type metastatic colorectal cancer: individual patient data pooled analy67
Extruded small extracellular vesicles: splinters of circulating tumour cells may promote cancer metastasis?66
Efficacy of FOLFIRI plus cetuximab vs FOLFIRI plus bevacizumab in 1st-line treatment of older patients with RAS wild-type metastatic colorectal cancer: an analysis of the randomised trial FIRE-364
Mismatch repair markers in preoperative and operative endometrial cancer samples; expression concordance and prognostic value64
Navigating therapeutic strategies: HPV classification in head and neck cancer63
The prognostic and biology of tumour-infiltrating lymphocytes in the immunotherapy of cancer63
Targeting mitochondrial oxidative phosphorylation: lessons, advantages, and opportunities62
The mental health impacts of receiving a breast cancer diagnosis: A meta-analysis62
Identifying health conditions associated with an increased risk of pancreatic ductal adenocarcinoma at medium term in nationwide electronic health records of primary care physicians62
DRP1 inhibition-mediated mitochondrial elongation abolishes cancer stemness, enhances glutaminolysis, and drives ferroptosis in oral squamous cell carcinoma60
Metabolic adaptations in prostate cancer60
Identifying optimal first-line treatment for advanced non-small cell lung carcinoma with high PD-L1 expression: a matter of debate59
Identification of increased dedifferentiation along the Prom1+ cancer cells in Müllerian adenosarcoma with sarcomatous overgrowth58
Hypoxia- and Postirradiation reoxygenation-induced HMHA1/ARHGAP45 expression contributes to cancer cell invasion in a HIF-dependent manner58
Long-term trends in incidence, characteristics and prognosis of screen-detected and interval cancers in women participating in the Dutch breast cancer screening programme58
Circulating tumour DNA monitoring and early treatment for relapse: views from patients with early-stage melanoma57
Risk of subsequent primary oral cancer in a cohort of 69,460 5-year survivors of childhood and adolescent cancer in Europe: the PanCareSurFup study57
Somatic hits in mismatch repair genes in colorectal cancer among non-seminoma testicular cancer survivors55
Randomised phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer54
Prognostic relevance of the neurological symptom burden in brain metastases from breast cancer54
The impact of the first 2 years of the COVID-19 pandemic on breast cancer diagnoses: a population-based study in England54
0.95872092247009